Skip to content

Can providing real-time warnings and feedback to physicians within a hospital information system reduce inappropriate glucocorticoid prescription?

Feedback intervention model of gradient boosted decision tree (GBDT) for glucocorticoid prescription control in primary care institutions: a cross-over randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN11747547
Enrollment
320
Registered
2021-12-02
Start date
2022-06-01
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prescription of glucocorticoids for common infectious diseases in primary care institutions Not Applicable

Interventions

A randomized crossover controlled trial (multicenter) will be conducted in 78 primary care institutions randomly selected from HIS. The primary care institutions will be randomly divided into two grou

Sponsors

Guizhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Have the same HIS system 2. 78 public primary hospitals with more than 3 outpatient doctors who can write 100 prescriptions every 10 days on average and who have been working continuously for at least 1 year

Exclusion criteria

Exclusion criteria: 1. Do not meet inclusion criteria 2. Do not have the right to prescribe 3. Refuse to accept intervention

Design outcomes

Primary

MeasureTime frame
The 10-day glucocorticoid prescriptions rate of the physicians, defined as the number of glucocorticoid prescriptions divided by the total number of prescriptions in each 10-day time period. A ‘prescription' refers to each glucocorticoid. The glucocorticoid prescription rate is assessed using hospital pharmacy stock records during the 3-month intervention period.

Secondary

MeasureTime frame
The rational rate of glucocorticoid prescription, defined as the reasonable number of glucocorticoids prescribed during the study period divided by the total amount of glucocorticoids prescribed throughout the study period

Countries

China

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 7, 2026